Kimelman & Baird, LLC Pfizer Inc Transaction History
Kimelman & Baird, LLC
- $1.25 Trillion
- Q3 2024
A detailed history of Kimelman & Baird, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Kimelman & Baird, LLC holds 46,941 shares of PFE stock, worth $1.18 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
46,941
Previous 46,941
-0.0%
Holding current value
$1.18 Million
Previous $1.31 Billion
3.43%
% of portfolio
0.11%
Previous 0.11%
Shares
1 transactions
Others Institutions Holding PFE
# of Institutions
3,256Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$13 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.7 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.3 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.11 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.27 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $141B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...